Confidential Commercial Information. (a) Executive acknowledges that she will be entrusted with price lists, customer lists, customer contact information, information about customer transactions, development and research work, marketing programs, plans, and proposals, and data contained within internally employed software, data bases, and computer operations developed by or for the Company (“Confidential Commercial Information”); provided, however, that for the purposes of this Agreement Confidential Commercial Information does not include information (i) that was publicly available prior to Executive’s disclosure or use thereof; or (ii) that Executive lawfully received from some person who was not under any obligation of confidentiality with respect thereto; (iii) that becomes publicly available other than as the result of any breach of this Agreement by Executive; or (iv) that is generally known to or readily ascertainable by proper means by other persons who can obtain economic value from its disclosure or use. Executive acknowledges that Confidential Commercial Information derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use, and that the Company has made efforts that are reasonable under the circumstances to maintain the secrecy of Confidential Commercial Information.
Confidential Commercial Information. Execution Version
Confidential Commercial Information. The National Institute of Justice Compliance Testing Program (hereafter, the NIJ CTP) shall use reasonable efforts to maintain confidential all information identified as “Confidential Commercial Information” that it obtains from the Applicant. Confidential Commercial Information shall not include information that is (a) publicly available; (b) subsequently acquired by the NIJ CTP from other sources in a manner that does not constitute a breach of this Agreement; (c) disclosed by the NIJ CTP when deemed, at its sole discretion, to be necessary to the NIJ CTP’s performance of the requested conformity assessment; (d) required to be produced pursuant to an order or command of any judicial or regulatory authority; (e) required by any common law or statutory duty; or (f) disclosed in the interest of officer safety. The NIJ CTP shall take reasonable steps to safeguard Applicant data within the NIJ CTP systems prior to external transmission and may transmit Applicant's Confidential Information and data to Applicant through the Internet or any public network, unless otherwise directed in writing by Applicant. Test ID: Final Model Designation: Applicant Name: Applicant Address: Telephone: The Applicant hereby expressly acknowledges and agrees as follows:
Confidential Commercial Information. CLIENT and BENECARD PBF agree not to use or disclose the other’s proprietary, trade secrets, and confidential information (“Confidential Information”) to any third party, while this Agreement is in effect or after its expiration or termination, except (1) as specifically contemplated by this Agreement; (2) with the other’s prior written consent; (3) as required by Law; or (4) to the extent such information becomes generally available to the public, through no action or fault of the receiving party. Such Confidential Information shall include, but not be limited to: with respect to BENECARD PBF: the terms and conditions of this Agreement; BENECARD PBF’s business operations and strategies; Pharmacy and Therapeutics Committee meeting minutes, procedures, processes and protocols; Pharmacy reimbursement rates including, but not limited to, MAC lists; Pharmacy and pharmaceutical manufacturer agreements; Formulary and Rebate information; reporting packages, and BENECARD PBF’s clinical and pharmacy audit services, algorithms, procedures, processes, and protocols; and with respect to CLIENT: its business operations and strategies. CLIENT and BENECARD PBF shall cease using the other’s Confidential Information upon termination of this Agreement or a subsequent agreement between the parties and shall return or destroy such information at the disclosing party’s written direction.
Confidential Commercial Information. Execution Version 9.8 A failure by Owner to have Owner’s Representative or other duly qualified agent present at tests, inspections, and approvals after due notice shall be deemed to be a waiver of Owner’s right to attend such tests, trials, and inspections.
Confidential Commercial Information. The competent authorities, eFTI services providers and economic operators concerned shall take measures to ensure confidentiality of commercial information processed and exchanged in accordance with this Regulation and ensure that such information can be accessed and processed only when authorised.
Confidential Commercial Information. Execution Version due to changes in Builder’s production approach or unless otherwise mutually agreed in writing.
Confidential Commercial Information. Execution Version due to any Change Order. Changes in steel weight as a result of a Change Order shall be addressed in accordance with Article 10.
Confidential Commercial Information. Execution Version When Builder is required to make a payment under a subcontract required by the Work in a non-United States currency, if the exchange rate for such currency as quoted in The Wall Street Journal (xxxxx://xxx.xxx.xxx/market-data/currencies/exchangerates) differs from the Base Rate for such currency, then the Contract Price shall be adjusted accordingly. Builder shall prepare, and Builder and Owner shall execute, Change Orders pursuant to Article 10 on a quarterly basis reflecting such increases or decreases in the Contract Price.
Confidential Commercial Information. Execution Version or the payment of any undisputed amounts as determined pursuant to Section 4.8.
